Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1067588/000119312504211210/dex991.htm
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1067588/000119312504211210/dex991.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aclara Biosciences Inc.
Aclara Biosciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:
CIK: 1067588Events:
Form Type: 8-K Corporate News
Accession Number: 0001193125-04-211210
Submitted to the SEC: Fri Dec 10 2004 5:21:52 PM EST
Accepted by the SEC: Fri Dec 10 2004
Period: Friday, December 10, 2004
Industry: Measuring And Controlling Devices